Related Experiment Video
Updated: Apr 9, 2026

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
Published on: January 18, 2019
Serious adverse events associated with yellow fever vaccine
Reinaldo de Menezes Martins1, Maria da Luz Fernandes Leal, Akira Homma
1a Bio-Manguinhos/Fiocruz ; Rio de Janeiro , Brazil.
Abstract:
Yellow fever vaccine was considered one of the safest vaccines, but in recent years it was found that it could rarely cause invasive and disseminated disease in some otherwise healthy individuals, with high lethality. After extensive studies, although some risk factors have been identified, the real cause of causes of this serious adverse event are largely unknown, but findings point to individual host factors. Meningoencephalitis, once considered to happen only in children less than 6 months of age, has also been identified in older children and adults, but with good prognosis. Efforts are being made to develop a safer yellow fever vaccine, and an inactivated vaccine or a vaccine prepared with the vaccine virus envelope produced in plants are being tested. Even with serious and rare adverse events, yellow fever vaccine is the best way to avoid yellow fever, a disease of high lethality and should be used routinely in endemic areas, and on people from non-endemic areas that could be exposed, according to a careful risk-benefit analysis.
Insights
The yellow fever vaccine is highly effective but can rarely cause severe illness due to unknown host factors. Safer vaccine development is ongoing, but current recommendations emphasize its importance for disease prevention.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Yellow fever vaccine is crucial for preventing a lethal disease.
- Rare severe adverse events, including invasive disease and meningoencephalitis, have been reported.
- The exact causes of these adverse events remain largely unknown, with a focus on individual host factors.
Purpose of the Study:
- To review the safety profile of the yellow fever vaccine.
- To discuss the rare but serious adverse events associated with the vaccine.
- To highlight ongoing efforts in developing safer vaccine alternatives.
Main Methods:
- Review of existing studies on yellow fever vaccine safety.
- Analysis of reported cases of severe adverse events.
- Evaluation of research into novel vaccine technologies.
Main Results:
- The yellow fever vaccine is generally safe but can rarely cause invasive, disseminated disease with high mortality.
- Meningoencephalitis, previously seen only in infants, is now identified in older individuals with a better prognosis.
- Individual host factors are implicated as a primary cause of severe adverse events.
Conclusions:
- Despite rare adverse events, the yellow fever vaccine remains the most effective method for preventing yellow fever.
- Routine vaccination is recommended in endemic areas and for at-risk travelers.
- Development of safer yellow fever vaccines, such as inactivated or plant-based envelope vaccines, is in progress.
Related Concept Videos
Arboviral Encephalitis
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Hypersensitivity Reactions: Cytolytic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Drug Toxicity: Allergic Reactions
Vaccinations

